The failure of HMGN1 by itself to halt the growth of CT26 tumors might be due to the immunosuppressive tumor microenvironment that hindered the elimination of tumor cells by CT26-specific cytotoxic T lymphocytes (CTLs). Here, HMGN1 is linked to neoplasm.